Cryo-Cell Intl Inc (CCEL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 11/30
| 02-2022 | 11-2021 | 08-2021 | 05-2021 | 02-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,145 | 8,263 | 7,701 | 7,948 | 11,278 |
| Marketable Securities | 472 | 75 | 74 | 73 | 86 |
| Receivables | 5,152 | 5,253 | 5,449 | 5,216 | 5,639 |
| Inventories | 928 | 921 | 834 | 890 | 868 |
| Other current assets | 484 | 711 | 350 | 306 | 315 |
| TOTAL | $9,717 | $15,783 | $14,921 | $14,783 | $18,696 |
| Non-Current Assets | |||||
| PPE Net | 3,805 | 3,230 | 3,028 | 1,553 | 1,597 |
| Investments And Advances | 308 | 308 | 308 | 308 | 308 |
| Intangibles | 17,889 | 18,153 | 18,406 | 18,670 | 61,766 |
| Other Non-Current Assets | 23,090 | 23,189 | 22,761 | 23,004 | 22,897 |
| TOTAL | $45,091 | $44,880 | $44,503 | $43,535 | $86,568 |
| Total Assets | $54,808 | $60,662 | $59,424 | $58,318 | $105,265 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,848 | 1,490 | 999 | 1,236 | 860 |
| Accrued Expenses | 2,104 | 3,057 | 1,647 | 1,491 | 3,457 |
| Other current liabilities | 1,933 | 4,958 | 4,916 | 4,890 | 13,307 |
| TOTAL | $16,387 | $21,074 | $19,858 | $20,120 | $29,845 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 326 | 1,086 |
| Deferred Revenues | 9,057 | 9,359 | 9,326 | 9,101 | 8,881 |
| Other Non-Current Liabilities | 2,017 | 4,130 | 4,371 | 4,743 | 48,078 |
| TOTAL | $34,170 | $35,404 | $34,767 | $34,196 | $77,115 |
| Total Liabilities | $50,557 | $56,478 | $54,625 | $54,315 | $106,960 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 8,460 | 8,503 | 8,530 | 8,445 | 7,981 |
| Common Shares | 147 | 147 | 146 | 145 | 137 |
| Retained earnings | -15,904 | -16,736 | -16,099 | -16,956 | -18,126 |
| Other shareholders' equity | 358 | 187 | 437 | 437 | 437 |
| TOTAL | $4,251 | $4,184 | $4,799 | $4,003 | $-1,695 |
| Total Liabilities And Equity | $54,808 | $60,662 | $59,424 | $58,318 | $105,265 |